The Pertussis Vaccine Market size is expected to grow at an annual average of 6% during 2021-2027. Pertussis vaccine is used for whooping cough. This vaccine can only be used in combination with other vaccines. The whooping cough vaccine is recommended for all children, infants, teens, and pregnant women. The diphtheria, tetanus, and pertussis (DTaP) vaccine is given to children under 7 years of age, and the tetanus, diphtheria, and whooping cough (Tdap) vaccine is given to older children and adults. Childhood immunization is one of the safest and most cost-effective methods for a pertussis-free environment. The World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) recommend that all children be vaccinated against pertussis on a regular basis.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Pertussis Vaccine Market at: https://www.orionmarketreports.com/request-sample/?id=78162
The following segmentation are covered in this report:
By Product
- Whole-cell vaccines
- Acellular vaccines
By Application
- Children
- Adults
Company Profile
- Sanofi Pasteur
- GSK
- Mitsubishi Tanabe Pharma
- Astellas Pharma
- Minhai Biotechnology
- Wuhan Institute of Biological Products
- Changchun Changsheng Life Sciences
The report covers the following objectives:
- Proliferation and maturation of trade in the global Pertussis Vaccine Market
- The market share of the global Pertussis Vaccine Market supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the Pertussis Vaccine Market
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Pertussis Vaccine Market
Scope of the report
The research study analyses the Pertussis Vaccine Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent developments
- Market overview and growth analysis
- Import and export overview
- Volume analysis
- Current market trends and future outlook
- Market opportunistic and attractive investment segment
A full report of Pertussis Vaccine Market is available at: https://www.orionmarketreports.com/pertussis-vaccine-market/78162/
Geographic coverage
- North america market size and/or volume
- Latin america market size and/or volume
- Europe market size and/or volume
- Asia-pacific market size and/or volume
- Rest of the world market size and/or volume
Key Questions Answered by Pertussis Vaccine Market Report
- What was the Pertussis Vaccine Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
- What will be the CAGR of Market during the forecast period (2021-2027)?
- Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
- Which manufacturer/vendor/players in the Pertussis Vaccine Market was the market leader in 2020?
- Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
About us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company name: Orion Market Reports
Contact person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
